/
/
/

Bafna Pharmaceuticals Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)296.60
Volume (₹)2,762.00
High (₹)296.60
Upper Circuit307.85
Low (₹)296.60
Lower Circuit295.85
Prev Close301.85
52W High (₹)318.50
Price296.60
52W Low (₹)94.77

Share Market Cap & Key Ratios Overview

M.Cap (₹)715.72 Cr
Div. Yield (%)0.00
PE Ratio91.90
Debt to Equity0.39
Price to Book2.78
Book Value40.64
EPS (TTM)3.29
Face Value10.00
ROE (%)12.27

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
BAFNAPH-BENSE
LTP
1W Low
1W High
Market cap (₹)
1901.6-18.4 (-0.96%)
1900.10
1984.80
4,56,833Cr
9189-50 (-0.54%)
9087
9467
2,45,426Cr
4859-191 (-3.78%)
4857
5066
1,87,320Cr
1132.6-58.4 (-4.90%)
1125.10
1187
1,13,217Cr
1380.6-42.9 (-3.01%)
1376.70
1426.10
1,12,212Cr
1853.1-85.4 (-4.41%)
1811.70
1949
1,01,155Cr
2123.2-48.3 (-2.22%)
2118.10
2192
97,626Cr
2336.3-46.6 (-1.96%)
2335
2419.20
96,859Cr
1161.9-16.1 (-1.37%)
1154.40
1179.90
96,406Cr
1659.4+14.1 (0.86%)
1622.60
1717
93,614Cr
296.6+5.5 (1.89%)
291
318.50
716Cr

Key Highlights of Bafna Pharmaceuticals Ltd Balance Sheet

Bafna Pharmaceuticals Ltd balance sheet discloses shareholders' funds of ₹23.66Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹23.66Cr, and the reserves and surplus of the company is ₹72.49Cr.

The company has its non-current liabilities with total liabilities of ₹175.53Cr as of 2026-03-31.

The current liabilities are ₹57.19Cr as of 2026-03-31. At the same time, current assets are ₹89.65Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of 5000 and tangible assets of ₹81.79Cr, provided in the Bafna Pharmaceuticals Ltd financial statements.